Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
1. The study will assess the safety and tolerability of a single-infusion of zoledronic
acid 5 mg administered in a private medical practice setting by a nurse provided by a
nationwide infusion service. Safety data will largely be monitored by investigating
changes in the patients' well-being during the study.
2. The study will pilot and test a Patient Registry and Infusion Service process, which
will allow zoledronic acid to be administered to trial patients in the investigators'
private rooms by a team of roving nurses.